Patients with biallelic NARS2 mutations usually had bilateral sensorineural hearing impairments (75%, 15/20) in early life (first 3 months), followed by different types of seizures (95.6%, 22/23) within 1 year of age, mainly status epilepticus. The gene discussed is NARS2; the disease is hearing loss disorder.